References
- Sutton JA, Clauss RP. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials. Brain Inj. 2017;31:1019–27.
- Machado C, Estévez M, Pérez-Nellar J, Gutiérrez J, Rodríguez R, Carballo M, Chinchilla M, Machado A, Portela L, García-Roca MC, et al. EEG, and behavioral arousal signs in a PVS case after Zolpidem intake. Can J Neurol Sci. 2011;38:341–44.
- Rodriguez-Rojas R, Machado C, Alvarez L, Carballo M, Estevez M, Perez-Nellar J, Pavon N, Chinchilla M, Carrick FR, Defina P. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS. Brain Inj. 2013;27(11):1320–29.
- Wyss PA, Radanovic D, Meier-Abt PJ. Acute overdose of zolpidem (Stilnox). Schweiz Med Wochenschr. 1996;126:750–56.
- Machado C, Estevez M, Rodriguez R, Perez-Nellar J, Chinchilla M. Zolpidem arousing effect in persistent vegetative state patients: autonomic, EEG and behavioral assessment. Current Pharmaceutical Design. 2014;20:4185–202.